Protein transduction technology offers a novel therapeutic approach for diabetes

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 13, Issue 4, 2006, Pages 306-313

  Noguchi, Hirofumi ^a,b,c   Matsumoto, Shinichi ^a,d  

^a Diabetes Research Institute Kyoto   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Diabetes; Insulin resistance; Islet regeneration; Islet transplantation; Protein transduction

Indexed keywords

ANTENNAPEDIA PROTEIN; ANTISENSE OLIGONUCLEOTIDE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; I KAPPA B KINASE BETA; INSULIN; IRON; ISLET BRAIN 1; JNK INTERACTING PROTEIN 1; LIPOSOME; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; PEPTIDE DERIVATIVE; PEPTIDE NUCLEIC ACID; POLYARGININE; POLYLYSINE; PROTEIN DERIVATIVE; PROTEIN INHIBITOR; PROTEIN VP22; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TACROLIMUS; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ISLET 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; VIVIT PROTEIN;

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; DRUG DELIVERY SYSTEM; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PLASMID; PROTEIN DOMAIN; PROTEIN TRANSPORT; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DIABETES MELLITUS; ENDOCYTOSIS; GENE PRODUCTS, TAT; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN RESISTANCE; ISLETS OF LANGERHANS TRANSPLANTATION; PROTEIN TRANSPORT; STEM CELL TRANSPLANTATION; TOXINS, BIOLOGICAL; TRANS-ACTIVATORS;

EID: 33746355256     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-005-1038-4     Document Type: Review

References (74)

1. JP Boyle AA Honeycutt KM Narayan TJ Hoerger LS Geiss H Chen 2001 Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S Diabetes Care 24 1936-40 11679460 1:STN:280:DC%2BD3MrntF2jsA%3D%3D
2. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-86 10.1056/NEJM199309303291401
3. UK Prospective 1998 Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-53 10.1016/S0140-6736(98)07019-6
4. Y Ohkubo H Kishikawa E Araki T Miyata S Isami S Motoyoshi 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study Diabetes Res Clin Pract 28 103-17 7587918 1:CAS:528:DyaK2MXpsVWgtrs%3D 10.1016/ 0168-8227(95)01064-K
5. AM Shapiro JR Lakey EA Ryan GS Korbutt E Toth GL Warnock 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 230-8 10911004 1:CAS:528:DC%2BD3cXlvVSmt7k%3D 10.1056/NEJM200007273430401
6. S Matsumoto T Okitsu Y Iwanaga H Noguchi H Nagata Y Yonekawa 2005 Insulin independence after living-donor distal pancreatectomy and islet allotransplantation Lancet 365 1642-4 15889479 1:CAS:528:DC%2BD2MXktVGku70%3D 10.1016/S0140-6736(05)66383-0
7. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method. Transplantation 2005; in press
8. CG Perry JR Petrie 2002 Insulin-sensitising agents: Beyond thiazolidinediones Expert Opin Emerg Drugs 7 165-74 15989542 1:CAS:528:DC%2BD38XltlOks7k%3D 10.1517/14728214.7.1.165
9. H Noguchi H Kaneto GC Weir S Bonner-Weir 2003 PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells Diabetes 52 1732-7 12829640 1:CAS:528:DC%2BD3sXltlWhtb8%3D
10. H Noguchi M Matsushita S Matsumoto YF Lu H Matsui S Bonner-Weir 2005 Mechanism of PDX-1 protein transduction Biochem Biophys Res Commun 332 68-74 15896300 1:CAS:528:DC%2BD2MXkt1OjtLc%3D 10.1016/j.bbrc.2005.04.092
11. Noguchi H, Matsumoto S, Okitsu T, Iwanaga Y, Yonekawa Y, Nagata H, et al. PDX-1 protein is internalized by lipid raft-dependent macropinocytosis. Cell Transplant 2005; in press
12. A Prochiantz 2000 Messenger proteins: Homeoproteins, TAT and others Curr Opin Cell Biol 12 400-6 10873818 1:CAS:528:DC%2BD3cXlt1Srtbw%3D 10.1016/ S0955-0674(00)00108-3
13. A Joliot A Prochiantz 2004 Transduction peptides: From technology to physiology Nat Cell Biol 6 189-96 15039791 1:CAS:528:DC%2BD2cXhs1Ggt7g%3D 10.1038/ncb0304-189
14. M Matsushita H Noguchi YF Lu K Tomizawa H Michiue ST Li et al.2004 Photo-acceleration of protein release from endosome in the protein transduction system FEBS Lett 572 221-6 15304352 1:CAS:528:DC%2BD2cXmsVGhtrk%3D 10.1016/j.febslet.2004.07.033
15. G Elliott P O'Hare 1997 Intercellular trafficking and protein delivery by a herpesvirus structural protein Cell 88 223-33 9008163 1:CAS:528:DyaK2sXpsV2lsA%3D%3D 10.1016/S0092-8674(00)81843-7
16. SR Schwarze A Ho A Vocero-Akbani SF Dowdy 1999 In vivo protein transduction: Delivery of a biologically active protein into the mouse Science 285 1569-72 10477521 1:CAS:528:DyaK1MXlslOru78%3D 10.1126/ science.285.5433.1569
17. T Watanabe N Shibata KA Westerman T Okitsu JE Allain M Sakaguchi et al.2003 Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers Transplantation 75 1873-80 12811248 1:CAS:528:DC%2BD3sXks1yqurs%3D 10.1097/01.TP.0000064621.50907.A6
18. T Matsumura M Takesue KA Westerman T Okitsu M Sakaguchi T Fukazawa et al. 2004 Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT Transplantation 77 1357-65 15167590 1:CAS:528:DC%2BD2cXlvVSitrg%3D 10.1097/01.TP.0000124286.82961.7E
19. C Bonny A Oberson S Negri C Sauser DF Schorderet 2001 Cell-permeable peptide inhibitors of JNK: Novel blockers of beta-cell death Diabetes 50 77-82 11147798 1:CAS:528:DC%2BD3MXis1Ontw%3D%3D
20. H Kaneto Y Nakatani T Miyatsuka D Kawamori TA Matsuoka M Matsuhisa et al.2004 Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide Nat Med 10 1128-32 15448687 1:CAS:528:DC%2BD2cXnvFyntbg%3D 10.1038/nm1111
21. J Embury D Klein A Pileggi M Ribeiro S Jayaraman RD Molano et al.2001 Proteins linked to a protein transduction domain efficiently transduce pancreatic islets Diabetes 50 1706-13 11473028 1:CAS:528:DC%2BD3MXlslKnur8%3D
22. H Noguchi M Matsushita T Okitsu A Moriwaki K Tomizawa S Kang et al.2004 A new cell-permeable peptide allows successful allogeneic islet transplantation in mice Nat Med 10 305-9 14770176 1:CAS:528:DC%2BD2cXhs1Wnuro%3D 10.1038/nm994
23. H Noguchi Y Nakai S Matsumoto M Kawaguchi M Ueda T Okitsu et al2005 Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function Am J Transplant 5 1848-55 15996231 1:CAS:528:DC%2BD2MXpsVaru7s%3D 10.1111/ j.1600-6143.2005.00985.x
24. M Matsushita K Tomizawa A Moriwaki ST Li H Terada H Matsui 2001 A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation J Neurosci 21 6000-7 11487623 1:CAS:528:DC%2BD3MXlvFKmsL4%3D
25. JC Mai H Shen SC Watkins T Cheng PD Robbins 2002 Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate J Biol Chem 277 30208-18 12034749 1:CAS:528:DC%2BD38XmsVKhsbY%3D 10.1074/ jbc.M204202200
26. S Futaki T Suzuki W Ohashi T Yagami S Tanaka K Ueda et al. 2001 Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J Biol Chem 276 5836-40 11084031 1:CAS:528:DC%2BD3MXhs1KmtL0%3D 10.1074/ jbc.M007540200
27. MC Morris P Vidal L Chaloin F Heitz G Divita 1997 A new peptide vector for efficient delivery of oligonucleotides into mammalian cells Nucleic Acids Res 25 2730-6 9207018 1:CAS:528:DyaK2sXks1GksL0%3D 10.1093/nar/ 25.14.2730
28. M Pooga U Soomets M Hallbrink A Valkna K Saar K Rezaei et al,1998 Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo Nat Biotechnol 16 857-61 9743120 1:CAS:528:DyaK1cXlvFWktbw%3D 10.1038/nbt0998-857
29. CG Ostenson AC Sandberg-Nordqvist J Chen M Hallbrink D Rotin U Langel et al2002 Overexpression of protein-tyrosine phosphatase PTP sigma is linked to impaired glucose-induced insulin secretion in hereditary diabetic Goto-Kakizaki rats Biochem Biophys Res Commun 291 945-50 11866457 10.1006/bbrc.2002.6536
30. F Simeoni MC Morris F Heitz G Divita 2003 Insight into the mechanism of the peptide-based gene delivery system MPG: Implications for delivery of siRNA into mammalian cells Nucleic Acids Res 31 2717-24 12771197 1:CAS:528:DC%2BD3sXkt1Wqs7o%3D 10.1093/nar/gkg385
31. M Lewin N Carlesso CH Tung XW Tang D Cory DT Scadden et al 2000 Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat Biotechnol 18 410-4 10748521 1:CAS:528:DC%2BD3cXis1Gmt7s%3D 10.1038/74464
32. VP Torchilin R Rammohan V Weissig TS Levchenko 2001 TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc Natl Acad Sci USA 98 8786-91 11438707 1:CAS:528:DC%2BD3MXls1Witbg%3D 10.1073/ pnas.151247498
33. M Sakaguchi T Nukui H Sonegawa H Murata J Futami H Yamada et al. 2005 Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei Nucleic Acids Res 33 e8815920103 10.1093/nar/gni088
34. S Futaki W Ohashi T Suzuki M Niwa S Tanaka K Ueda et al. 2001 Stearylated arginine-rich peptides: A new class of transfection systems Bioconjug Chem 12 1005-11 11716693 1:CAS:528:DC%2BD3MXnvVWmtrk%3D 10.1021/bc015508l
35. JP Richard K Melikov E Vives C Ramos B Verbeure MJ Gait et al 2003 Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J Biol Chem 278 585-90 12411431 1:CAS:528:DC%2BD38XpvVWnsrk%3D 10.1074/jbc.M209548200
36. G Drin S Cottin E Blanc AR Rees J Temsamani 2003 Studies on the internalization mechanism of cationic ell-penetrating peptides J Biol Chem 278 31192-201 12783857 1:CAS:528:DC%2BD3sXmtFequrw%3D 10.1074/ jbc.M303938200
37. H Noguchi S Bonner-Weir FY Wei M Matsushita S Matsumoto 2005 BETA2/ NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence Diabetes 54 2859-66 16186386 1:CAS:528:DC%2BD2MXhtV2rs77J
38. JS Wadia RV Stan SF Dowdy 2004 Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat Med 10 310-5 14770178 1:CAS:528:DC%2BD2cXhs1Wnurg%3D 10.1038/nm996
39. R Fischer K Kohler M Fotin-Mleczek R Brock 2004 A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides J Biol Chem 279 12625-35 14707144 1:CAS:528:DC%2BD2cXitl2gtrs%3D 10.1074/ jbc.M311461200
40. K Sandvig B van Deurs 2000 Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives EMBO J 19 5943-50 11080141 1:CAS:528:DC%2BD3cXovVaisLs%3D 10.1093/emboj/19.22.5943
41. JM Lord LM Roberts 1998 Toxin entry: Retrograde transport through the secretory pathway J Cell Biol 140 733-6 9472027 1:CAS:528:DyaK1cXhtlegt7k%3D 10.1083/jcb.140.4.733
42. S Matsumoto K Tanaka 2005 Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs) J Hepatobiliary Pancreat Surg 12 227-30 15995811 10.1007/s00534-005-0978-z
43. S Matsumoto SA Qualley S Goel DK Hagman IR Sweet V Poitout et al. 2002 Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol Transplantation 74 1414-9 12451242 1:CAS:528:DC%2BD38XptVSiurg%3D 10.1097/00007890-200211270-00013
44. S Matsumoto TH Rigley JA Reems Y Kuroda RB Stevens 2003 Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition Am J Transplant 3 53-63 12492711 1:CAS:528:DC%2BD3sXotFCisw%3D%3D 10.1034/ j.1600-6143.2003.30110.x
45. S Matsumoto Y Kuroda 2002 Perfluorocarbon for organ preservation before transplantation Transplantation 74 1804-9 12499904 1:CAS:528:DC%2BD38Xpslaku7c%3D 10.1097/00007890-200212270-00030
46. T Matsuda Y Suzuki Y Tanioka H Toyama K Kakinoki K Hiraoka et al. 2003 Pancreas preservation by the 2-layer cold storage method before islet isolation protects isolated islets against apoptosis through the mitochondrial pathway Surgery 134 437-45 14555931 10.1067/ S0039-6060(03)00165-X
47. KK Rehman S Bertera R Bottino AN Balamurugan JC Mai Z Mi et al. 2003 Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide J Biol Chem 278 9862-8 12524423 1:CAS:528:DC%2BD3sXhvV2hsbw%3D 10.1074/jbc.M207700200
48. MM Ribeiro D Klein A Pileggi RD Molano C Fraker C Ricordi et al. 2003 Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells Biochem Biophys Res Commun 305 876-81 12767912 1:CAS:528:DC%2BD3sXktFGju78%3D 10.1016/S0006-291X(03)00856-8
49. D Klein MM Ribeiro V Mendoza S Jayaraman NS Kenyon A Pileggi et al. 2004 Delivery of Bcl-XL or its BH4 domain by protein transduciton inhibits apoptosis in human islets Biochem Biophys Res Commun 323 473-8 15369775 1:CAS:528:DC%2BD2cXnsVyqtrg%3D 10.1016/j.bbrc.2004.08.116
50. J Aramburu MB Yaffe C Lopez-Rodriguez LC Cantley PG Hogan A Rao 1999 Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A Science 285 2129-33 10497131 1:CAS:528:DyaK1MXmt12jtLY%3D 10.1126/science.285.5436.2129
51. M Hibi A Lin T Smeal A Minden M Karin 1993 Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain Genes Dev 7 2135-48 8224842 1:CAS:528:DyaK2cXisVyksQ%3D%3D
52. B Derijard M Hibi IH Wu T Barrett B Su T Deng et al. 1994 JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 76 1025-37 8137421 1:CAS:528:DyaK2cXjtFygt78%3D 10.1016/0092-8674(94)90380-8
53. RJ Davis 2000 Signal transduction by the JNK group of MAP kinases Cell 103 239-52 11057897 1:CAS:528:DC%2BD3cXns1Cltrk%3D 10.1016/ S0092-8674(00)00116-1
54. L Chang M Karin 2001 Mammalian MAP kinase signaling cascades Nature 410 37-40 11242034 1:CAS:528:DC%2BD3MXhvVSgs7k%3D 10.1038/35065000
55. J Hirosumi G Tuncman L Chang CZ Gorgun KT Uysal K Maeda et al. 2002 A central role for JNK in obesity and insulin resistance Nature 420 333-6 12447443 1:CAS:528:DC%2BD38XovVekt7g%3D 10.1038/nature01137
56. V Aguirre T Uchida L Yenush R Davis MF White 2000 The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J Biol Chem 275 9047-54 10722755 1:CAS:528:DC%2BD3cXit1emt7Y%3D 10.1074/ jbc.275.12.9047
57. AM Manning RJ Davis 2003 Targeting JNK for therapeutic benefit: From junk to gold? Nat Rev Drug Discov 2 554-65 12815381 1:CAS:528:DC%2BD3sXks1Oru7c%3D 10.1038/nrd1132
58. H Kaneto G Xu N Fujii S Kim S Bonner-Weir GC Weir 2002 Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression J Biol Chem 277 30010-8 12011047 1:CAS:528:DC%2BD38XmsVKhs7o%3D 10.1074/jbc.M202066200
59. D Kawamori Y Kajimoto H Kaneto Y Umayahara Y Fujitani T Miyatsuka et al. 2003 Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase Diabetes 52 2896-904 14633849 1:CAS:528:DC%2BD3sXpsFagsLg%3D
60. JA Corbett JL Wang MA Sweetland JR Lancaster Jr ML McDaniel 1992 Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide J Clin Invest 90 2384-91 1334975 1:CAS:528:DyaK3sXnvFSrtw%3D%3D
61. H Kaneto J Fujii HG Seo K Suzuki T Matsuoka M Nakamura et al. 1995 Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells Diabetes 44 733-8 7540572 1:CAS:528:DyaK2MXms1Cnu7g%3D
62. A Ammendrup A Maillard K Nielsen N Aabenhus Andersen P Serup O Dragsbaek Madsen et al. 2000 The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells Diabetes 49 1468-76 10969830 1:CAS:528:DC%2BD3cXmsVOrsLk%3D
63. C Bonny A Oberson M Steinmann DF Schorderet P Nicod G Waeber 2000 IB1 reduces cytokine-induced apoptosis of insulin-secreting cells J Biol Chem 275 16466-72 10748095 1:CAS:528:DC%2BD3cXjvFCntL4%3D 10.1074/ jbc.M908297199
64. T Mandrup-Poulsen 2001 beta-cell apoptosis: Stimuli and signaling Diabetes 50 Suppl 1 S58-63 11272204 1:CAS:528:DC%2BD3MXhtVOgtrY%3D
65. G Waeber J Delplanque C Bonny V Mooser M Steinmann C Widmann et al. 2000 The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes Nat Genet 24 291-5 10700186 1:CAS:528:DC%2BD3cXhvFaqt7Y%3D 10.1038/73523
66. J Dominguez-Bendala D Klein M Ribeiro C Ricordi L Inverardi R Pastori et al. 2005 TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro Diabetes 54 720-6 15734848 1:CAS:528:DC%2BD2MXitlegs74%3D
67. K Kilk M Magzoub M Pooga LE Eriksson U Langel A Graslund 2001 Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide Bioconjug Chem 12 911-6 11716681 1:CAS:528:DC%2BD3MXnvFGmtro%3D 10.1021/bc0100298
68. B Ensoli L Buonaguro G Barillari V Fiorelli R Gendelman RA Morgan et al. 1993 Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J Virol 67 277-87 8416373 1:CAS:528:DyaK3sXlsl2qtg%3D%3D
69. A Joliot A Maizel D Rosenberg A Trembleau S Dupas M Volovitch et al. 1998 Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein Curr Biol 8 856-63 9705930 1:CAS:528:DyaK1cXks1Ghtbc%3D 10.1016/S0960-9822(07)00346-6
70. A Prochiantz A Joliot 2003 Can transcription factors function as cell-cell signaling molecules? Nat Rev Mol Cell Biol 4 814-9 14570063 1:CAS:528:DC%2BD3sXovFOlsr4%3D
71. FJ Naya HP Huang Y Qiu H Mutoh FJ DeMayo AB Leiter et al. 1997 Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice Genes Dev 11 2323-34 9308961 1:CAS:528:DyaK2sXmtl2hu7k%3D
72. J Jonsson L Carlsson T Edlund H Edlund 1994 Insulin-promoter-factor 1 is required for pancreas development in mice Nature 371 606-9 7935793 1:CAS:528:DyaK2cXmsFahsbg%3D 10.1038/371606a0
73. S Marshak E Benshushan M Shoshkes L Havin E Cerasi D Melloul 2000 Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate beta-cell-specific expression Mol Cell Biol 20 7583-90 11003654 1:CAS:528:DC%2BD3cXnt1ait7w%3D 10.1128/MCB.20.20.7583-7590.2000
74. T Miyachi H Maruyama T Kitamura S Nakamura H Kawakami 1999 Structure and regulation of the human NeuroD (BETA2/BHF1) gene Brain Res Mol Brain Res 69 223-31 10366743 1:CAS:528:DyaK1MXjsVShu7Y%3D 10.1016/ S0169-328X(99)00112-6